Antonio Colombo

Summary

Affiliation: EMO Centro Cuore Columbus
Country: Italy

Publications

  1. ncbi request reprint Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
    Antonio Colombo
    Ospedale San Raffaele, Milano, Italy
    Circulation 108:788-94. 2003
  2. ncbi request reprint Percutaneous coronary intervention in patients with a single remaining vessel
    Davide Tavano
    San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 99:470-1. 2007
  3. pmc Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
    Cosmo Godino
    Department of Cardio Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy
    Thromb J 7:4. 2009
  4. doi request reprint Stenting unprotected left main: the outcome is not always favorable
    Antonio Colombo
    Cardiac Cath Lab and Interventional Cardiology, EMO Centro Cuore Colombus and San Raffaele Hospital, Milan, Italy
    Catheter Cardiovasc Interv 71:539-40. 2008
  5. ncbi request reprint Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions
    John Cosgrave
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:1663-8. 2005
  6. ncbi request reprint Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
    Dejan Orlic
    EMO, Centro Cuore Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:1154-60. 2004
  7. doi request reprint Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation
    Kensuke Takagi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 78:432-43. 2011
  8. doi request reprint Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    JACC Cardiovasc Interv 3:1110-21. 2010
  9. doi request reprint Prolonged double antiplatelet therapy in a cohort of "de novo" diabetic patients treated with drug-eluting stent implantation
    Nadia Mollichelli
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 105:1395-401. 2010
  10. doi request reprint A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation
    Gill Louise Buchanan
    San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 81:579-83. 2013

Detail Information

Publications130 found, 100 shown here

  1. ncbi request reprint Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
    Antonio Colombo
    Ospedale San Raffaele, Milano, Italy
    Circulation 108:788-94. 2003
    ..Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after treatment of de novo coronary lesions in small patient populations...
  2. ncbi request reprint Percutaneous coronary intervention in patients with a single remaining vessel
    Davide Tavano
    San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 99:470-1. 2007
    ..In conclusion, these data support percutaneous intervention as a realistic treatment option for this often highly symptomatic and difficult-to-treat patient cohort...
  3. pmc Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
    Cosmo Godino
    Department of Cardio Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy
    Thromb J 7:4. 2009
    ..abstract:..
  4. doi request reprint Stenting unprotected left main: the outcome is not always favorable
    Antonio Colombo
    Cardiac Cath Lab and Interventional Cardiology, EMO Centro Cuore Colombus and San Raffaele Hospital, Milan, Italy
    Catheter Cardiovasc Interv 71:539-40. 2008
  5. ncbi request reprint Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions
    John Cosgrave
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:1663-8. 2005
    ..Overall, the 2 available stent platforms had similar performance characteristics...
  6. ncbi request reprint Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
    Dejan Orlic
    EMO, Centro Cuore Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:1154-60. 2004
    ..This study evaluated clinical outcome after multivessel stenting with sirolimus-eluting stents (SES) in unselected lesions...
  7. doi request reprint Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation
    Kensuke Takagi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 78:432-43. 2011
    ..To investigate the predictors of moderate-to-severe aortic regurgitation (AR≥2+) after CoreValve implantation and evaluate the feasibility and safety of postdilatation in reducing the degree of AR...
  8. doi request reprint Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    JACC Cardiovasc Interv 3:1110-21. 2010
    ..Our aim was to assess clinical outcome after transcatheter aortic valve implantation (TAVI) performed with the 2 commercially available valves with 3 delivery approaches selected in a stepwise fashion...
  9. doi request reprint Prolonged double antiplatelet therapy in a cohort of "de novo" diabetic patients treated with drug-eluting stent implantation
    Nadia Mollichelli
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 105:1395-401. 2010
    ..42, 95% confidence interval 4.99 to 83.62). In conclusion, DM remains an independent adverse factor on clinical outcome. In this setting, prolonged DAT, even beyond that recommended in the guidelines, might be beneficial...
  10. doi request reprint A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation
    Gill Louise Buchanan
    San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 81:579-83. 2013
    ..To describe results from our "modified crossover technique" for vascular access management during transcatheter aortic valve implantation (TAVI)...
  11. doi request reprint 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience
    Alaide Chieffo
    Interventional Cardiology Unit, Department of Cardio Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 3:595-601. 2010
    ....
  12. doi request reprint A new technique for vascular access management in transcatheter aortic valve implantation
    Andrew S P Sharp
    San Raffaele Scientific Institute and Columbus Hospitals, Milan, Italy
    Catheter Cardiovasc Interv 75:784-93. 2010
    ..To describe results from a novel percutaneous technique designed to minimize the risk of hemorrhage in the event of a major complication during transcatheter aortic valve implantation...
  13. doi request reprint Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)
    Cosmo Godino
    San Raffaele Institute, Milan, Italy
    EuroIntervention 5:906-16. 2010
    ..The objective of this study was to evaluate "real world" long-term outcome following paclitaxel-eluting stent (PES) implantation for unprotected LMCA disease in patients enrolled in the TRUE registry...
  14. ncbi request reprint Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique
    Antonio Colombo
    Catheterization Laboratory, San Raffaele Hospital, Milan, Italy
    Catheter Cardiovasc Interv 64:407-11; discussion 412. 2005
    ..This technique appears a promising approach to recanalize difficult total occlusions, particularly the ones localize on the RCA, which has the most important side branches located distally...
  15. doi request reprint Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation
    Rasha Al-Lamee
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 4:87-95. 2011
    ..The aim of this study was to evaluate the incidence, predictors, management, and clinical outcomes in patients with grade III coronary perforation during percutaneous coronary intervention...
  16. ncbi request reprint Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery
    Eleftheria Tsagalou
    San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 45:1570-3. 2005
    ..We sought to determine the safety and efficacy of using multiple overlapping drug-eluting stents (DES) in patients with diffuse left anterior descending coronary artery (LAD) disease...
  17. ncbi request reprint Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis
    Flavio Airoldi
    San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 97:1182-7. 2006
    ..The association of diffuse restenosis and diabetes mellitus is an unfavorable condition leading to a high risk of recurrence...
  18. ncbi request reprint Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era
    Giuseppe G L Biondi-Zoccai
    St Raffaele Hospital, Milan, Italy
    Am J Cardiol 95:1466-8. 2005
    ..Such results may provide useful information to guide prevention of this complication...
  19. ncbi request reprint Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
    Eur Heart J 27:540-6. 2006
    ..However, their role after drug-eluting stent (DES) implantation is still undescribed. We assessed incidence, predictors, and outcomes of residual dissections in DES-treated lesions...
  20. ncbi request reprint Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation
    Giuseppe Tarantini
    EMO Centro Cuore Columbus, San Raffaele Hospital, Milan, Italy
    Ital Heart J 4:843-9. 2003
    ..The predictors of outcome in such patients after coronary stenting have not been clarified...
  21. doi request reprint Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 4:155-64. 2011
    ..This study sought to evaluate the long-term angiographic and clinical outcomes after the treatment of drug-eluting stent in-stent restenosis (DES-ISR) based on the angiographic pattern of restenosis...
  22. ncbi request reprint Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 49:2320-8. 2007
    ..This study was designed to compare the outcomes of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) in a contemporaneous cohort of real-world patients...
  23. ncbi request reprint Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    Catheter Cardiovasc Interv 60:145-51. 2003
    ..Angiographic follow-up is necessary to prove the advantage of this specific technique to give complete coverage of the ostium of the side branch with a drug-eluting stent...
  24. ncbi request reprint Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents
    Pierfrancesco Agostoni
    San Raffaele Hospital, Milan, Italy
    Am J Cardiol 99:593-8. 2007
    ..Thus, late loss may not be a reliable marker of the true efficacy of these devices due to its complex and nongaussian distribution...
  25. doi request reprint Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry
    Kensuke Takagi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circ Cardiovasc Interv 6:154-60. 2013
    ..In this study, we evaluated the immediate results and follow-up of patients with ULM-percutaneous interventions and with or without associated CTO-RCA...
  26. ncbi request reprint Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient
    Ioannis Iakovou
    EMO Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 64:436-9; discussion 440-1. 2005
    ..Multiple (> or =4) SES implantation appears safe with no increase in major adverse cardiac events...
  27. doi request reprint Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates
    Maurizio Taramasso
    Cardiothoracic Department, San Raffaele Scientific Institute, Milan, Italy
    EuroIntervention 8:429-36. 2012
    ..The aim of the study was to investigate the changes in quality of life (QoL) following transcatheter aortic valve implantation (TAVI) up to two years' follow-up...
  28. doi request reprint Incidence of overall bleeding in patients treated with intra-aortic balloon pump during percutaneous coronary intervention: 12-year Milan experience
    Giedrius Davidavicius
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 5:350-7. 2012
    ....
  29. doi request reprint Clinical outcomes following protected carotid artery stenting in symptomatic and asymptomatic patients
    Alfonso Ielasi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    J Endovasc Ther 17:298-307. 2010
    ..To evaluate clinical outcomes in patients undergoing carotid artery stenting (CAS) with routine use of a cerebral embolic protection device (EPD)...
  30. ncbi request reprint Is overdilatation of 3.0 mm sirolimus-eluting stent associated with a higher restenosis rate?
    Ioannis Iakovou
    EMO, Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 64:129-33. 2005
    ..These data should lessen concern that overdilation may dilute the beneficial effects of SESs...
  31. ncbi request reprint Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside
    Flavio Airoldi
    San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 99:916-20. 2007
    ..In conclusion, the standardized protocol of intracoronary NTP administration succeeded in normalizing SCF in all patients with AMI but in only 5 of 9 patients with SVG stenosis. This latter subgroup requires other therapeutic strategies...
  32. ncbi request reprint Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    Am Heart J 153:354-9. 2007
    ..Currently, little data are available on the management of drug-eluting stent (DES) restenosis. Drug resistance may play a role in its etiology...
  33. doi request reprint Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve
    Irene Franzoni
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 112:554-9. 2013
    ..LBBB persists in most patients, but in this cohort, it was not a predictor of overall or cardiovascular mortality or permanent pacemaker implantation...
  34. doi request reprint Comparison of first- and second-generation drug-eluting stents in saphenous vein grafts used as aorto-coronary conduits
    Charis Costopoulos
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 112:318-22. 2013
    ..479), 18.1% versus 14.2% (p = 0.465), and 15.0% versus 10.7% (p = 0.373), respectively. In conclusion, second-generation DES are at least comparable with first-generation DES with regard to clinical outcomes at midterm follow-up...
  35. doi request reprint Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry)
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    Am J Cardiol 102:1002-8. 2008
    ..The rate of subacute and late stent thrombosis was low in this subgroup of patients...
  36. ncbi request reprint Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions
    Antonio Colombo
    EMO Centro Cuore Columbus, Milan, Italy
    Circulation 109:1244-9. 2004
    ..A sirolimus-eluting stent (Cypher, Cordis Corp) has been reported to markedly decrease restenosis in selected lesions; higher-risk lesions, including coronary bifurcations, have not been studied...
  37. doi request reprint Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    EuroIntervention 7:1275-84. 2012
    ..Transcatheter valve-in-valve (VIV) implantation may offer a less invasive alternative. The aim of this study was to report our initial experience with transcatheter VIV implantation to treat degenerated tissue valves...
  38. ncbi request reprint Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans
    Renu Virmani
    Catheterization Laboratories, Ospedale San Raffaele and Emo Centro Cuore Columbus, Milan, Italy
    Circulation 106:2649-51. 2002
    ..This study presents the histological findings of atherectomy specimens from a subset of these patients receiving implants...
  39. doi request reprint Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation
    Renata Rogacka
    San Raffaele Scientific Institute, Via Olgettina 60, Milan, Italy
    JACC Cardiovasc Interv 1:56-61. 2008
    ..The purpose of this study was to evaluate the safety of dual antiplatelet therapy in patients in whom long-term anticoagulation (AC) with warfarin is recommended...
  40. ncbi request reprint Late restenosis following sirolimus-eluting stent implantation
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 100:41-4. 2007
    ..In conclusion, late restenosis is an infrequent but real entity; its existence implies we should not discount the possibility of restenosis as the cause of symptoms that develop >1 year after sirolimus-eluting stent implantation...
  41. ncbi request reprint Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery
    Takuro Takagi
    EMO Centro Cuore Columbus, Milan, Italy
    Circulation 106:698-702. 2002
    ..The safety and efficacy of percutaneous coronary intervention of de novo lesions in unprotected left main coronary arteries remains an unresolved issue...
  42. ncbi request reprint Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation
    Lei Ge
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 46:613-20. 2005
    ..The purpose of this research was to evaluate the long-term outcomes after implantation of drug-eluting stents (DES) in bifurcation lesions with the "crush" technique...
  43. ncbi request reprint Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience
    Alaide Chieffo
    Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy
    Circulation 113:2542-7. 2006
    ..Improvements in results with percutaneous coronary intervention (PCI) with drug-eluting stents (DES) may extend their use in patients with left main coronary artery (LMCA) stenosis...
  44. ncbi request reprint Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    Ioannis Iakovou
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    JAMA 293:2126-30. 2005
    ..However, delayed endothelialization associated with the implantation of drug-eluting stents may extend the risk of thrombosis beyond 30 days. Data are limited regarding the risks and the impact of this phenomenon outside clinical trials...
  45. ncbi request reprint Early and mid-term results of drug-eluting stent implantation in unprotected left main
    Alaide Chieffo
    San Raffaele Hospital, Milan, Italy
    Circulation 111:791-5. 2005
    ..The safety and efficacy of percutaneous coronary intervention in unprotected left main (ULM) coronary arteries are still a matter of debate...
  46. doi request reprint Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience
    Maurizio Taramasso
    Cardiac Surgery Department, San Raffaele University Hospital, Milan, Italy
    Eur J Cardiothorac Surg 42:920-6. 2012
    ..Mitraclip therapy is an emerging option for selected high-risk patients with FMR. The aim of this study was to report the outcomes of patients who underwent a surgical mitral repair and Mitraclip therapy for FMR in our experience...
  47. doi request reprint Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study
    Azeem Latib
    Interventional Cardiology Unit, EMO GVM Centro Cuore Columbus, Milan, Italy
    Am Heart J 164:910-7. 2012
    ..Limited real-world data comparing outcomes after transcatheter (TAVR) and surgical aortic valve replacement (SAVR) in intermediate-surgical-risk patients with aortic stenosis are available...
  48. doi request reprint Managing patients with an indication for anticoagulant therapy after transcatheter aortic valve implantation
    Filippo Figini
    Interventional Cardiology Unit, S Raffaele Scientific Institute, Milan, Italy Interventional Cardiology Unit, EMO GVM Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 111:237-42. 2013
    ..When bleeding was a concern, especially in the absence of coronary disease, warfarin alone was prescribed. These results suggest that this approach is safe, but data from larger, randomized studies are needed...
  49. ncbi request reprint A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing transcatheter aortic valve implantation (TAVI): is it a valid alternative to rapid pacing? A prospective pilot study
    Giedrius Davidavicius
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    J Invasive Cardiol 23:467-71. 2011
    ..A risk of inducing myocardial ischemia with RRVP remains, especially in patients with left ventricular dysfunction. Alternatively, a transient cardiac arrest can be achieved with administration of adenosine...
  50. doi request reprint Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry
    Kensuke Takagi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circ Cardiovasc Interv 5:491-8. 2012
    ..Few data are available regarding the optimal revascularization strategy for unprotected distal left main coronary artery (UDLM) in-stent restenosis (ISR)...
  51. doi request reprint Coronary chronic total occlusions: mid-term comparison of clinical outcome following the use of the guided-STAR technique and conventional anterograde approaches
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    Catheter Cardiovasc Interv 79:20-7. 2012
    ....
  52. ncbi request reprint Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
    Flavio Airoldi
    Invasive Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circulation 116:745-54. 2007
    ..The need for prolonged aspirin and thienopyridine therapy and the risk of stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents...
  53. ncbi request reprint Drug-eluting stent restenosis the pattern predicts the outcome
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 47:2399-404. 2006
    ..We sought to determine if the angiographic pattern of in-stent restenosis in drug-eluting stents (DES) maintains its prognostic importance...
  54. doi request reprint Subintimal tracking and re-entry technique with contrast guidance: a safer approach
    Mauro Carlino
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 72:790-6. 2008
    ..To assess the procedural and clinical outcomes from a modified subintimal tracking and re-entry (STAR) procedure performed using contrast guidance...
  55. ncbi request reprint Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions
    Shinichi Furuichi
    Invasive Cardiology Unit, San Raffaele Scientific Institute and EMO Centro Cuore Columbus, Milan, Italy
    EuroIntervention 5:370-4. 2009
    ..The aim of this study was to evaluate the outcome of patients with severe lesion calcification undergoing RA followed by implantation of DES...
  56. ncbi request reprint Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents
    Eleftheria Tsagalou
    The San Raffaele Hospital, Milan, Italy
    Am J Cardiol 97:187-91. 2006
    ..93 mm, p = 0.0001) in the DES group. In conclusion, DES implantation in de novo ostial LAD lesions appears safe and effective and is associated with a significant decrease in restenotic rates compared with historical experience with BMSs...
  57. doi request reprint [Multimodality imaging in transcatheter aortic valve implantation procedures: the pivotal role of echocardiography]
    Antonio Grimaldi
    Dipartimento Cardio Toraco Vascolare, Universita Vita Salute, Milano, Italy
    G Ital Cardiol (Rome) 12:652-63. 2011
    ....
  58. doi request reprint Computed tomography-based evaluation of aortic annulus, prosthesis size and impact on early residual aortic regurgitation after transcatheter aortic valve implantation
    Nicola Buzzatti
    Department of Cardiac Surgery, San Raffaele Hospital, Milan, Italy
    Eur J Cardiothorac Surg 43:43-50; discussion 50-1. 2013
    ..The aim of this study was to analyse the role of CT in the choice of prosthesis and the prevention of residual aortic regurgitation (RAR)...
  59. ncbi request reprint Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions
    Ioannis Iakovou
    Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 44:967-71. 2004
    ..This observational study evaluated the clinical and angiographic outcomes of patients with aorto-ostial coronary artery disease treated with sirolimus-eluting stents (SESs) or with bare metal stents (BMSs)...
  60. ncbi request reprint In-stent restenosis in small coronary arteries: impact of strut thickness
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 40:403-9. 2002
    ..OBJECTIVES; We sought to evaluate whether strut thickness may impact the restenosis rate after stent implantation in small coronary arteries...
  61. doi request reprint Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study
    Ahmed Rezq
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 5:1264-72. 2012
    ..The aim of this study was to explore the incidence, causes, and outcomes of cardiac tamponade in patients undergoing transcatheter aortic valve implantation (TAVI)...
  62. doi request reprint Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circ Cardiovasc Interv 3:249-56. 2010
    ..Concerns about the long-term safety of drug-eluting stents (DES) in saphenous vein grafts has become an area of controversy and uncertainty...
  63. doi request reprint The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry
    Gill Louise Buchanan
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    EuroIntervention 7:556-63. 2011
    ..To assess outcomes after transcatheter aortic valve implantation (TAVI) according to sex, with the two available valves and four recognised delivery approaches...
  64. doi request reprint Clinical outcomes after unrestricted implantation of everolimus-eluting stents
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 2:1219-26. 2009
    ..The aim of this study was to evaluate the efficacy and safety of unrestricted everolimus-eluting stent (EES) implantation in a contemporary cohort of real-world patients...
  65. ncbi request reprint 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease
    Flavio Airoldi
    Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:664-7. 2005
    ..47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-beta-E eluting stent over the control PC stent...
  66. ncbi request reprint Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure
    Ioannis Iakovou
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 94:351-4. 2004
    ....
  67. ncbi request reprint Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease
    Flavio Airoldi
    EMO Centro Cuore, Columbus Hospital, Milan, Italy
    Am J Cardiol 93:474-7. 2004
    ..5% in the CC group vs 32.7% in the SS group; p = 0.675). In unselected patients and lesions, carbon coating does not provide significant improvements over SS stents with the same design...
  68. ncbi request reprint Initial experience with a new 8 French-compatible directional atherectomy catheter: immediate and mid-term results
    Dejan Orlic
    Catheterization Laboratory, Columbus Hospital, Milan, Italy
    Catheter Cardiovasc Interv 60:159-66. 2003
    ..Plaque debulking with the FHT catheter can be performed safely and effectively in relatively small vessels and complex lesions located in mid-distal artery segments with 6-month clinical outcome similar to prior atherectomy devices...
  69. ncbi request reprint Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis
    Flavio Airoldi
    EMO Centro Cuore, Columbus Clinic, Interventional Cardiology Unit, San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 94:1297-300. 2004
    ..The results indicate a good safety profile of the procedure and a 57% reduction in the incidence of recurrent restenosis in comparison with cutting balloon angioplasty...
  70. ncbi request reprint A novel approach to chronic total occlusions: the crosser system
    Gloria Melzi
    EMO Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 68:29-35. 2006
    ..To evaluate safety and efficacy of the CROSSER CTO Recanalization System (CROSSER)...
  71. ncbi request reprint Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    Circulation 107:2178-80. 2003
    ..Restenosis after implantation of drug-eluting stents (DES) is a rare phenomenon, occurring more frequently peri-stent...
  72. ncbi request reprint Drug-eluting stent implantation in coronary trifurcation lesions
    Shinichi Furuichi
    San Raffaele Scientific Institute and EMO Centro Cuore Columbus, Milan, Italy
    J Invasive Cardiol 19:157-62. 2007
    ..There is no specific study evaluating the outcome of DES implantation in trifurcation lesions...
  73. doi request reprint Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve
    Marco Mussardo
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 4:743-50. 2011
    ..The aim of this study was to analyze the short-term outcomes after transcatheter aortic valve implantation with the Edwards Sapien THV (ESV), compared with the Sapien XT THV (SXT) (Edwards Lifesciences, Irvine, California)...
  74. ncbi request reprint Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations
    Goran Stankovic
    Columbus Hospital, Milan, Italy
    Am J Cardiol 93:213-6. 2004
    ..The incidence of adverse events, emergency coronary artery bypass grafting and death significantly decreased over time...
  75. doi request reprint Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques
    Rasha Al-Lamee
    San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 106:1721-7. 2010
    ..The repeat revascularization rates were high; however, graft patency was achievable in most after reintervention...
  76. ncbi request reprint Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am Heart J 156:745-50. 2008
    ..The aim of the study was to compare the outcomes of sirolimus-eluting (SES) and paclitaxel-eluting (PES) stent implantation in coronary bifurcations treated with either a 1-stent or 2-stent strategy...
  77. doi request reprint Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score
    Robert T Gerber
    Catheterisation Laboratory, San Raffaele Hospital, 20132, Milan, Italy
    Cardiovasc Revasc Med 12:220-7. 2011
    ..Limited information exists concerning clinical and angiographic outcomes following multiple stent insertion. We therefore present the long-term outcome from drug-eluting stent (DES) insertion and correlate this with the Syntax score...
  78. doi request reprint Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions
    Rasha Al-Lamee
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 108:1055-60. 2011
    ..In conclusion, despite differences in baseline characteristics favoring the BMS group, PCI with DES in AO lesions was associated with improved outcomes, with lower restenosis, revascularization, and major adverse cardiac event rates...
  79. ncbi request reprint Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents
    Alaide Chieffo
    San Raffaele Hospital, Milan, Italy
    Circulation 109:2732-6. 2004
    ..We report the occurrence of this event during elective implantation of sirolimus-eluting stents...
  80. doi request reprint Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents
    Alaide Chieffo
    Department of Cardio Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 104:1660-7. 2009
    ..The different smooth muscle cell phenotypes within the stent types might suggest different mechanisms of restenosis...
  81. ncbi request reprint Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
    Konstantinos Toutouzas
    Centro Cuore Columbus, Milan, Italy
    J Invasive Cardiol 15:722-4. 2003
  82. ncbi request reprint Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE)
    Giuseppe G L Biondi-Zoccai
    Mediolanum Cardio Research, Milan, Italy
    Int J Cardiol 117:349-54. 2007
    ..Indeed, the TRUE Study, including as much as 115 ULM and 229 bifurcation interventions, should give important insights into the outcome of PES in such an unprecedented and challenging context...
  83. doi request reprint Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform
    Nedy Brambilla
    Department of Interventional Cardiology, Sant Ambrogio Clinical Institute, Milan, Italy
    J Cardiovasc Med (Hagerstown) 10:852-8. 2009
    ....
  84. doi request reprint Bifurcation disease: what do we know, what should we do?
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 1:218-26. 2008
    ..Dedicated bifurcation stents are an exciting new technology that may further simplify the management of bifurcation PCI and change some of these concepts...
  85. ncbi request reprint Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting
    Antonio Colombo
    EMO Centro Cuore Columbus and San Raffaele Hospitals, Milan, Italy
    Catheter Cardiovasc Interv 63:61-2. 2004
  86. ncbi request reprint Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention
    Takahiro Nishida
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 89:1257-62. 2002
    ..Nonobstructive dissections can be left untreated when final IVUS reveals an area stenosis of < 60% at the site of a dissection...
  87. ncbi request reprint Outcome of treatment of aorto-ostial lesions involving the right coronary artery or a saphenous vein graft with a polytetrafluoroethylene-covered stent
    Konstantinos Toutouzas
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 90:63-6. 2002
  88. doi request reprint Does IVUS guidance of coronary interventions affect outcome? a prime example of the failure of randomized clinical trials
    Robert Gerber
    EMO Centro Cuore Columbus and San Raffaele Hospitals, Milan, Italy
    Catheter Cardiovasc Interv 71:646-54. 2008
    ..We hope to demonstrate this statement with the completion of the angiographically versus IVUS optimization (AVIO) study that soon will be initiated...
  89. ncbi request reprint A new dedicated stent and delivery system for the treatment of bifurcation lesions: preliminary experience
    Konstantinos Toutouzas
    Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 58:34-42. 2003
    ..Treatment of bifurcation lesions with this new dedicated device appears to be feasible. This new device may introduce a new approach for the treatment of coronary bifurcation lesions...
  90. ncbi request reprint Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial
    Goran Stankovic
    Columbus Hospital, Milan, Italy
    Circulation 108:37-42. 2003
    ..Treatment of lesions located in saphenous vein grafts (SVGs) is associated with increased procedural risk and a high rate of restenosis...
  91. ncbi request reprint The lunar stent characteristics and clinical results
    Fabio Alfredo Sgura
    Department of Interventional Cardiology San Raffaele Hospital, Milan, Italy
    Herz 27:514-7. 2002
    ..Preliminary clinical and angiographic follow-up show a low rate of cardiac events at 6 months (16.1% MACE) and a moderate hyperplastic response...
  92. ncbi request reprint Modern strategies to prevent coronary restenosis
    Alaide Chieffo
    Laboratory of Interventional Cardiology, EMO Centro Cuore Columbus, Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy
    Ital Heart J 3:9S-15S. 2002
  93. ncbi request reprint Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
    Giuseppe G L Biondi-Zoccai
    Invasive Cardiology, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
    Int J Cardiol 100:119-23. 2005
    ..Drug-eluting stents (DES) have been recently investigated, with favorable data for many devices, but comparative data are lacking. We thus performed an adjusted indirect comparison metaanalysis of DES...
  94. ncbi request reprint Two-stent techniques for the treatment of coronary bifurcations with drug-eluting stents
    Ioannis Iakovou
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Hellenic J Cardiol 46:188-98. 2005
  95. ncbi request reprint Sidebranch patency during main branch stenting: try to keep the branch open immediate and long-term!
    Antonio Colombo
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    J Invasive Cardiol 14:503-4. 2002
  96. ncbi request reprint Selection of coronary stents
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 40:1021-33. 2002
    ....
  97. ncbi request reprint Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome
    Lei Ge
    EMO Centro Cuore Columbus, 48 Via M Buonarroti, 20145 Milan, Italy
    J Am Coll Cardiol 45:989-94. 2005
    ..The purpose of the present report was to evaluate clinical and angiographic outcomes of drug-eluting stent (DES) implantation in saphenous vein graft (SVG) lesions...
  98. ncbi request reprint Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel
    Simon J Corbett
    EMO Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 69:109-14. 2007
    ..To assess the safety and efficacy of concurrent implantation of sirolimus-eluting (SES) and paclitaxel-eluting (PES) stents in the same coronary artery...
  99. ncbi request reprint Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease)
    Antonio Colombo
    San Raffaele Scientific Institute and EMO Centro Cuore Columbus, 20145 Milan, Italy
    Circulation 116:1424-32. 2007
  100. doi request reprint Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Nat Clin Pract Cardiovasc Med 6:92-3. 2009
    ..Nevertheless, for patients with mild or no angina and no significant ischemia on stress testing, the COURAGE trial reassures us that OMT alone can be efficacious in reducing angina and/or improving quality of life...
  101. doi request reprint Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study
    Antonio Colombo
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circulation 119:71-8. 2009
    ..Sirolimus-eluting stents have been reported to be effective in the treatment of coronary bifurcations. Still, it has not been fully clarified which strategy would provide the best results with true bifurcation lesions...